GENE ONLINE|News &
Opinion
Blog

Liver
Astellas Ditches Gene Therapies, with Losses Exceeding $390 Million
2022-04-25
Homology Medicines Joins Biomarin in Gene Therapy Clinical Hold
2022-02-22
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Gannex Pharma Announces New Dual Targeting Drug for NASH
2022-01-05
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
R&D
NASH Drug Candidate, ASC42 Receives Fast Track Designation
2020-12-18
December 5, 2012: Scientists Discovered Over 3,000 Epigenetic Switches Control Daily Liver Cycles
2017-12-04
LATEST
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
An Interview with the Inventor of HPV Vaccine, Ian Frazer, Building a Firewall for Public Health
2024-02-29
Taiwan’s Drug Price Adjustments: Balancing Cost and Availability
2024-02-28
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
EVENT
Scroll to Top